Bioceres Crop
BIOX
Bioceres Crop (BIOX) earnings history
Most recent quarter
- Fiscal period
- Q4 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.39
- EPS estimate
- −$0.06
- EPS surprise
- −542.00%
- Revenue surprise
- −29.24%
- Revenue
- $55.9M
- Revenue estimate
- $79.0M
- Reported
- Sep 16, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2026 | Sep 16, 2026 | −$0.06 | −$0.39 | −542.00% | $55.9M | SEC |
| Q3 2026 | May 12, 2026 | −$0.05 | −$0.16 | −214.40% | $39.4M | SEC |
| Q1 2026 | Nov 13, 2025 | −$0.06 | −$0.12 | −86.89% | $77.5M | SEC |
| Q4 2025 | Sep 9, 2025 | $0.07 | −$0.70 | −1138.37% | $74.7M | SEC |
| Q3 2025 | May 21, 2025 | −$0.13 | −$0.02 | +83.44% | $60.6M | SEC |
| Q2 2025 | Feb 12, 2025 | $0.10 | $0.01 | −90.26% | $106.7M | SEC |
| Q1 2025 | Nov 12, 2024 | −$0.02 | −$0.08 | −283.18% | $93.3M | SEC |
| Q4 2024 | Sep 10, 2024 | $0.23 | −$0.03 | −114.06% | $124.0M | SEC |
| Q3 2024 | May 14, 2024 | $0.17 | $0.14 | −18.12% | $84.0M | SEC |
| Q2 2024 | Feb 9, 2024 | $0.09 | $0.02 | −79.57% | $140.2M | SEC |
| Q1 2024 | Nov 14, 2023 | $0.09 | −$0.07 | −177.78% | $116.6M | SEC |
| Q4 2023 | Sep 11, 2023 | $0.02 | −$0.06 | −400.50% | $104.7M | SEC |
| Q3 2023 | May 11, 2023 | −$0.03 | $0.44 | +1775.38% | $93.6M | SEC |
| Q2 2023 | Feb 9, 2023 | $0.07 | −$0.13 | −285.71% | $94.4M | SEC |
| Q1 2023 | Nov 14, 2022 | $0.05 | $0.04 | −27.08% | $127.1M | — |
| Q4 2022 | Sep 8, 2022 | $0.20 | −$0.12 | −160.36% | $105.7M | — |
| Q3 2022 | May 12, 2022 | −$0.08 | −$0.16 | −104.08% | $69.5M | — |
| Q2 2022 | Feb 10, 2022 | $0.18 | $0.08 | −56.59% | $92.7M | — |
| Q1 2022 | Nov 10, 2021 | $0.09 | $0.02 | −77.27% | $66.9M | — |
| Q4 2021 | Sep 30, 2021 | $0.19 | $0.02 | −89.58% | $82.2M | — |
Quarterly revenue
Frequently asked questions
When did Bioceres Crop (BIOX) last report earnings?
Bioceres Crop last reported on Sep 16, 2026, covering fiscal Q4 2026.
Did BIOX beat earnings estimates?
No. Bioceres Crop reported EPS of −$0.39 for Q4 2026 against a −$0.06 estimate — a 542.00% miss.
How much revenue did BIOX report last quarter?
Bioceres Crop reported $55.9M in revenue for Q4 2026, against a consensus estimate of $79.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.